| 000 | 01032 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517185811.0 | ||
| 264 | 0 | _c20190117 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2017.11.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatson, Kathleen | |
| 245 | 0 | 0 |
_aInsulin resistance, an unmasked culprit in depressive disorders: Promises for interventions. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c07 2018 |
||
| 300 |
_a327-334 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDepressive Disorder _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 700 | 1 | _aNasca, Carla | |
| 700 | 1 | _aAasly, Linn | |
| 700 | 1 | _aMcEwen, Bruce | |
| 700 | 1 | _aRasgon, Natalie | |
| 773 | 0 |
_tNeuropharmacology _gvol. 136 _gno. Pt B _gp. 327-334 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2017.11.038 _zAvailable from publisher's website |
| 999 |
_c27829856 _d27829856 |
||